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In 2020, the first clinical toxicology advanced nurse practitioner and independent 
prescriber post was introduced in the United Kingdom. This article discusses the 
remit of clinical toxicology and the integration of nurse prescribing into this service by 
following a patient journey from admission to discharge. The case study describes 
an acute paracetamol poisoning presentation following intentional self-harm.  
Paracetamol is widely available and safe in therapeutic dosages however it is the 
drug most commonly taken in intentional overdose and the toxic effect can result in 
hepatic failure and fatality. The nurse prescriber conducted a holistic consultation, 
assessed pharmacological management and instigated timely treatment. Current 
research on benefits and disadvantages of paracetamol antidote regimes are 
discussed.  Long-term physical and mental well-being following intentional overdose 
requires interprofessional liaison with access to psychological support arranged prior 
to patient discharge.    
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Paracetamol is an effective analgesic and antipyretic and safe to use in therapeutic 
dosages. 
Paracetamol is the most commonly used drug in acute overdose with intent to self-
harm. 
Early presentation and timely management of paracetamol poisoning can reduce 
severity of hepatocyte damage. 
Intravenous acetylcysteine has been the first line management for paracetamol 
poisoning since the 1970’s. 
Novel acetylcysteine regimens offer potential of shorter duration, equivalent efficacy 
and less adverse effects than historic regimens. 
 
 
Reflective sentences  
Do you highlight the limits of the therapeutic dosage when prescribing paracetamol?  
Did you know how to access the National Poisons Information Service? 











There has been an exponential and welcome growth in the number of healthcare 
professionals with an independent prescribing qualification in the United Kingdom 
(UK) since legislation was passed in 2006 (Stewart et al, 2017). The benefits of 
prescribing rights beyond the traditional medical practitioners for service provision, 
patient centred care and professional development are well documented (Graham-
Clarke et al. 2019). However, within clinical toxicology services the independent 
nurse prescribing role is a recent introduction, with the first UK clinical toxicology 
advanced nurse practitioner (ANP) and prescriber training post realised in Edinburgh 
in 2020 (EdinClinTox, 2020). This article will outline the remit of the clinical 
toxicology nurse prescriber and the UK National Poisons Information Service (NPIS) 
before presenting this novel prescribing role in a case study of paracetamol 
(acetaminophen) poisoning.  
 
UK National Poisons Information Service  
Regional NHS poisoning treatment centres were first established in the 1960’s 
following the Atkins and Hill reports which highlighted significant concerns regarding 
poisoning management nationally (Good 2014). This informal network of poisoning 
centres subsequently amalgamated to become the UK National Poisons Information 
Service.   The NPIS service is currently based in four NHS teaching hospitals: 
Birmingham, Cardiff, Newcastle and Edinburgh with links in London and York. 
Together they provide information on suspected exposures or poisonings involving a 
vast range of substances including pharmaceuticals, alternative medicines, drugs of 
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abuse, organic compounds, household and industrial chemicals.   Their remit 
includes NHS staff education on poisoning therapies; public health surveillance and 
clinical toxicology specialist research. The primary role of NPIS is to provide a 24 
hour clinical toxicology information service to healthcare professionals offering 
guidance on the management of poisoned patients. Most enquiries to the NPIS 
relate to paracetamol poisoning (NPIS 2020). 
The UK NPIS centre in Scotland is based in Edinburgh and this has responsibility for 
the provision of TOXBASE, an online clinical toxicology database.  This database 
provides global access to healthcare professionals to a reference resource for 
information on poisons and advice on the management of the poisoned patient.  All 
NHS facilities can register for free web access and 24 hour enquiry service for 
individual advice on complex presentations is available (Box 1).  
 
Website details: www.toxbase.org  
24-hour information for healthcare professionals: 0344 892 0111 
Members of the public should contact NHS advice centres, e.g. NHS 24, NHS 111 
or NHS Direct.  In Ireland contact NPIC. 
TOXBASE admin: mail@toxbase.org   
NPIS: www.npis.org  
 
Box 1. National Poisoning Information Service  
 
The Edinburgh NPIS centre initially employed specialist nurses but this role has 
evolved to clinical toxicology ANP and independent prescriber, creating a unique 
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opportunity to enhance the service. This is a first for UK clinical toxicology and the 
NPIS. As a speciality, clinical toxicology complements and supports the pillars of 
advanced practice and the underpinning drivers of nurse prescribing.  
The role of the clinical toxicology ANP encompasses cases within acute medicine, 
critical and emergency care and also outreach services.  The progression from 
specialist nurse to advanced practitioner with prescribing rights enables complete 
care provision, thus more therapeutic and empathetic relationship formations with 
service users. Additionally, toxicology patients can deteriorate rapidly depending on 
the substances ingested, or may be actively suicidal or experiencing acute 
psychoses. This can be a particularly emotionally challenging environment for health 
care professionals and developing an already familiar, experienced and supportive 
service to a more advanced level has been met with positivity. 
The following case discussion will focus on the prescribing role of the clinical 
toxicology ANP in a paracetamol poisoning presentation. Pseudonyms are used to 
protect patient confidentiality. 
 
Case presentation 
Alice presented to the emergency department three hours following a significant 
overdose of a single ingestion of 50 paracetamol tablets. She was a 21 year old 
female who was low in mood secondary to multiple social stressors. Clinically she 
was asymptomatic. On admission, she was regretful of the overdose and had 
actively sought help. She had no significant past medical history or previous contact 
with mental health services. The initial stage of the consultation focused on 
clarification of timings and content of the overdose. She was able to give the exact 
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time she had taken the tablets as it followed a phone conversation with her mother, 
which was logged on her mobile. She denied taking any other substances and had 
not drank alcohol.  
 
Paracetamol pharmacology 
Paracetamol is a low cost, widely available and effective analgesic and antipyretic 
which is licenced for use in mild to moderate pain, pyrexia and acute migraine 
(British National Formulary (BNF) 2020).  In certain preparations it is only available 
on prescription but can be purchased as an ‘over the counter’ medication in a range 
of dosages and in combination with other compounds.   Safe paracetamol dosage for 
an adult is 0.5 – 1 gram every 4-6 hours with a maximum dose of 4 grams per day 
(BNF 2020). 
The pharmacodynamic action of paracetamol is not fully understood but proposed 
mechanisms suggested include inhibiting COX enzymes, inhibiting prostaglandin 
synthesis, binding to receptors and ion channels and blocking the generation of pain 
impulses in the central nervous system (Bennett 2016).   
In therapeutic dosing, paracetamol is metabolised to produce the toxic metabolite N-
acetyl-para-benzoquinone imine (NAPQI) through oxidation via Cytochrome P450 
enzymes in the liver. Glutathione stored in the liver quickly combines with NAPQI in 
order to form non-toxic cysteine. Cysteine conjugates which can then be eliminated 
in the urine (Nelson et al. 2010). With a paracetamol overdose, it is believed that 
glutathione stores are depleted by the overwhelming volume of NAPQI.  The 
accumulation of NAPQI will bind to key cell components, commencing a sequence of 
events which may result in hepatocellular death (Thomas 2014). The ease of 
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availability of paracetamol makes it one of the most commonly used drugs 
associated with intentional overdose with approximately 50,000 acute hospital 
admission recorded in the UK annually (Pettie et al. 2019). 
 
Consultation  
Consultation is described as a two-way social exchange between practitioner and 
patient focused on interactive decision making (Perry 2011). For clinical toxicology 
practitioners it is essential that consultations are holistic and empathetic. The 
opportunity to facilitate open and genuine interaction to discuss issues such as 
suicidal ideation and drug and alcohol misuse is paramount (Vandewalle 2019). This 
patient group may be in a distressed or agitated state and strongly benefit from clear, 
honest and cohesive information regarding treatment plans.  Additionally, patients 
who self-harm report feeling marginalised by health care professionals in the acute 
care setting and previous experience of judgemental attitudes and behaviours may 
impede the formation of therapeutic relationships (Hamilton 2016).   
It was important to remain mindful of Alice’s emotional distress following an acute 
intentional overdose. A private, calm and safe environment was provided within 
which Alice was able to talk openly and honestly about the multiple stressors she felt 
where negatively contributing to her low mood.  The trigger which led to Alice 
consuming the overdose of paracetamol was a phone conversation with her mother 
and she volunteered that their relationship was emotionally complex.  Nuttall and 
Rutt-Howard (2011) introduced the theory of ego-states which can be applied to 
consultation, namely adult, parent and child. Performing consultations with an adult 
ego state creates effective and supportive communication whereas a parental ego 
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state often generates a barrier to the interaction leaving the patient feeling ultimately 
disempowered and frustrated, effectively taking on the child persona (Morris et al, 
2018). During consultation with Alice, active listening and reassurance was offered to 
demonstrate that her input was valued and taken into account. By engaging an adult 
ego-state this enabled Alice to be heard without interruption thus validated her 
concerns with the hope that this positive experience would continue to influence 
engagement with longer term support measures.  The systematic but individualised 
approach allowed a rapport to be built with Alice, she felt listened to while all 
pertinent information was gathered and a full examination performed whilst involving 
her in the decision- making process (McLeish and Snowden 2017). 
While following a consultation model is useful to guide assessment, it is equally 
important to maintain flexibility. Although the Calgary-Cambridge model provides a 
structure to follow while building a relationship, it does not cover all aspects of 
consultation and fusion with other models may be beneficial (Deness 2013).  The 
‘house-keeping’ aspect incorporated within the Neighbour model encourages the 
practitioner to ask whether they are equipped for the next consultation, 
acknowledging that fatigue, anxiety and stress can negatively affect clinical 
judgement (Mehay 2012). This approach may be particularly useful within clinical 
toxicology as patients are frequently emotionally labile, actively suicidal or suffering 
from acute withdrawals or psychosis. Taking time to ensure we are prepared to 
move on to the next consultation and reflecting on upsetting situations with 
colleagues is inherently valuable in this field. 
 
Clinical Assessment  
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In the instance of paracetamol overdose many presentations are initially clinically 
asymptomatic. However, some do experience nausea and vomiting and a gradual 
onset of abdominal discomfort which may indicate liver damage. Alice was 
asymptomatic but had she felt nauseous or actively vomiting then a prescription of 
antiemetics is warranted (Table 1). The most concerning toxic effect of paracetamol 
overdose is hepatic necrosis, features of which occur approximately two to three 
days post overdose (Thomas 2014). Without treatment renal tubular necrosis may 
develop and progressive damage to the liver may result in encephalopathy, coma 
and eventual death (BNF 2020). It is therefore vital that there is an accurate timeline, 
particularly time of ingestion, in order to gauge potential for harm and treatment 
options.  Paracetamol absorption is not complete before four hours post ingestion, 
therefore plasma concentration peaks at four hours (Chiew et al, 2016). The time 
and plasma concentration are plotted on a paracetamol nomogram to determine 
whether or not treatment is required (BNF2020) Within the UK, the nomogram 
categorises patients as requiring intervention if the concentration is above a 
‘treatment line’ which begins at 100mg/L at four hours (Bateman and Dear 2019). 
On review Alice’s blood results showed a plasma paracetamol concentration of 
190mg/L at four hours post ingestion.  From the significant plasma paracetamol 
concentration, it was evident that Alice required prompt treatment in order to 
minimise harm specifically the potential of liver failure.  Park, Dear and Antoine 
(2014) reviewed the efficacy and safety of interventions available as treatment 
modalities for acute paracetamol poisoning, which included activated charcoal, 
methionine and acetylcysteine. Non-pharmacological management included 
haemodialysis, for which Alice did not meet the criteria (Silvotti et al, 2013; Gosselin 
et al, 2014).  Neither did Alice present at a late stage with hepatic damage severe 
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Activated charcoal interferes with hydrolysis in the small intestine and actively 
absorbs many poisons within the gastric contents which limits their toxic effects 
(Wishart et al. 2020). If administered within one hour of ingestion activated charcoal 
can reduce the absorption of paracetamol (Chiew et al. 2017). However, it is 
inconclusive whether it improves long term clinical outcomes, specifically if it results 
in a reduction of mortality, hepatotoxicity or liver failure (Park et al. 2015). 
Additionally, activated charcoal can be unpalpable and difficult to consume.  
Activated charcoal should be considered if the presentation is within one hour of 
ingesting of a paracetamol overdose of greater than 150mg/kg (BNF 2020).  
As Alice was now more than four hours post ingestion prescribing activated charcoal 
would not have been therapeutic. 
 
Methionine versus Acetylcysteine 
The action of both methionine and acetylcysteine are similar. Both are precursors to 
cysteine, which acts as a precursor to glutathione thus replenishing stores to 
conjugate with NAPQI (Wishart et al. 2020).  The metabolism of paracetamol 
generates free radicals and both methionine and acetylcysteine have antioxidant 
qualities (Bateman and Dear 2019). However, within clinical toxicology literature 
there is little evidence to support methionine as a treatment option. Park et al. (2015) 
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proposed that there is the possibility that methionine reduces the risk of liver damage 
and mortality after paracetamol poisoning compared with supportive care, but the 
evidence is limited and inconclusive.  
Acetylcysteine has been the first line treatment globally for paracetamol poisoning 
since the 1970s when it was shown to dramatically reduce mortality and potential of 
hepatotoxicity (Prescott et al. 1979). Acetylcysteine is the only antidote advised for 
paracetamol poisoning by both the BNF and the NPIS (BNF, 2020; NPIS 
TOXBASE,2020).). The Medicines and Healthcare products Regulatory Agency 
advises intravenous acetylcysteine is practically 100% effective in preventing liver 
injury if given within eight hours of overdose (Freeman 2014). Therefore, as Alice 
presented before eight hours and was clinically stable but at risk of hepatocellular 
injury with a significant plasma paracetamol concentration, the initial prescribing 
decision was to commence treatment with intravenous acetylcysteine. 
Acetylcysteine Dosing & Regimens 
Acetylcysteine may be administered intravenously using the dose calculated by 
Prescott et al. (1979) with a single standard dosage based on weight following a 
three-step regimen (Table 2).  Following this treatment regimen blood tests are 
analysed for alanine aminotransferase (ALT) elevation indicating hepatocyte injury 
and international normalised ratio (INR) rise which may indicate impaired liver 
function. If required additional infusions with acetylcysteine are commenced if blood 
results indicate ongoing hepatic compromise (NPIS TOXBASE, 2020).  
Although this regimen has been overwhelmingly successful globally and considered 
‘standard’ treatment, the three-bag infusion course is complex, there is potential for 
miscalculation and there is a high incidence of side effects due to activated 
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histamine release (Hayes et al. 2008). Dose related vomiting and anaphylactoid 
reaction occur in up to 60% of patients in the initial treatment phase of the 
acetylcysteine regimen, which correspondingly leads to treatment interruption and 
refusal from 20% of patients (Sandilands et al. 2016).  
As the severity of anaphylactoid symptoms appear related to higher concentrations 
of acetylcysteine and the complexities of the regimen, Chiew et al. (2018) reviewed 
alternative delivery of acetylcysteine compared with the three-bag regimen. Of the 
identified studies the most pertinent to UK clinical toxicology was the SNAP trial 
(Scottish and Newcastle Antiemetic Pre-treatment for paracetamol poisoning) 
(Bateman et al. 2014). This trial hypothesised that a 12 hour, two bag course could 
be designed as an alternative to the standard 20 hour 15 minutes three bag regimen, 
while providing the required 300mg/kg plasma concentrations for liver protection. 
Patients were eligible if they presented with a single acute paracetamol overdose 
requiring treatment with acetylcysteine as per UK guidelines (BNF 2020). Adopting 
the SNAP modified acetylcysteine regimen, the incidence of symptomatic adverse 
effects was significantly reduced compared to the standard three bag regimen 
(Bateman et al. 2014). In 2015 the SNAP regimen was adopted into clinical practice 
for all patients requiring treatment for paracetamol overdose presenting in 
Edinburgh. The safety and efficacy of both standard and SNAP regimens were 
audited within NPIS centres by comparing blood results for liver injury at ten hours, 
which showed that the 12 hour acetylcysteine regimen was both safe and effective 
(Pettie et al. 2019).  Additionally, the SNAP regimen produced fewer adverse 
reactions and had comparable efficacy for preventing liver injury when compared to 
the original regimen. The shortened duration of therapy improved rates of adherence 
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to treatment. The SNAP regimen has now been approved by NPIS (2020) for 
national advice and has been adopted by many clinical areas globally. 
Alice was prescribed acetylcysteine as per SNAP protocol, prepared in sodium 
chloride rather than dextrose as she was not hypoglycaemic, a symptom associated 
with evolving liver impairment. She did not suffer anaphylactoid reactions during the 
initial phase of treatment, however if she had, the infusion could have been paused 
and antihistamine administered if required alongside a bronchodilator if any evidence 
of bronchospasm (Table 1). It is essential that the infusion is restarted once the 
reaction settles and it may be beneficial to slow the rate of infusion by running the 
first bag over four hours with the second bag running at the usual rate.  
Alice did not require extended treatment and was hospitalised for 18 hours in total. 
She made a full recovery with no long-term liver impairment or ongoing clinical 
issues. The clinical toxicology team works cohesively with the liaison psychiatry team 
ensuring all patients who have taken an intentional overdose with self-harm intent 
are cared for under a dual approach emphasising effective communication and 
shared learning. Alice was referred to the liaison team for ongoing support. 
 
Conclusion  
For a presentation of post single acute paracetamol overdose it is essential to clarify 
the history and timing of the event and obtain plasma paracetamol levels at 
appropriate time intervals in order to assess potential risk of liver injury.  Within one 
hour of ingestion administration of activated charcoal can reduce paracetamol 
absorption and after four hours intravenous acetylcysteine is recommended to 
minimise toxic impact.   The three-bag acetylcysteine regimen has been standard 
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practice but novel protocols including the SNAP regimen are now being adopted 
globally (Chiew et al. 2016).  Monitoring of biomarkers of hepatocyte injury should 
guide further pharmacological management.  Long-term health and well-being 
following intentional overdose requires interprofessional liaison to optimise both 
physical and mental health outcomes. This case study highlights the potential of the 
clinical toxicology advanced practitioner to provide holistic and timely management 
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Table 1. Medications indicated in paracetamol poisoning. 
Medication  Indication  Dose  Duration  Comments  
 
Antiemetic  Nausea and/or 
vomiting. 
Cyclizine 50 mg up to 3 
times a day.  
 
Ondansetron 4 mg  
8 hourly. 
As clinically indicated. May be early feature of 




Antihistamine Flushing, urticaria, 
angioedema. 
Chlorphenamine 4 mg  
4-6 hourly  
max 24 mg/day. 
As clinically indicated. Anaphylactoid adverse 
drug reaction to 
acetylcysteine. 
 
Bronchodilators Bronchospasm. Salbutamol nebuliser  
2.5- 5 mg up to 4 times 
daily. 
As clinically indicated. Anaphylactoid adverse 
drug reaction to 
acetylcysteine. 
 
Activated charcoal Paracetamol overdose.  50 g dose. Single dose. Presenting within 1 hour 
of ingestion of 
paracetamol. 
 
0.9% Sodium chloride  Acetylcysteine infusion. As per acetylcysteine 
regimen. 





Solution for preparation 
of acetylcysteine 
infusion.  
Glucose 5%   Acetylcysteine infusion 
with presenting 
hypoglycaemia. 
As per acetylcysteine 
regimen. 
As per acetylcysteine 
regimen. 
 
(BNF,2020; NPIS TOXBASE, 2020) 
 





Table 2. Intravenous acetylcysteine dosing regimens 
Regimen  1st infusion  2nd infusion  3rd infusion  Total duration  Extended infusion  
(blood test dependent) 
 
Prescott regimen  




over 15 minutes.  
50mg/kg  
over 4 hours.  
100mg/kg  
over 16 hours.  
20 hours 15 
minutes. 
100mg/kg  





over 1 hour.  
50mg/kg  
over 4 hours.  
100mg/kg 
 over 16 hours  
21 hours.  100mg/kg  




100mg/kg in 200mls  
over 2 hours.  
200mg/kg in 
1000mls  
over 10 hours.  
 12 hours.  200mg/kg  
over 10 hours. 
 
